PIMSTONE SIMON N. (CEO) sold 96.7% of their position (177.13K shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $6.78M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 6 sales
Filed: 8/16/2022ACC: 0001209191-22-046015
DirectorOfficer· CEO
Since Sep 2019
-177.13K
Net shares
Net seller
$6.78M
Total sold
6
Open market trades
0B · 6S
6
Total transactions
177.13K disposed
Non-Derivative Transactions6
Common Shares
Direct
Shares
−43.13K
Price / share
$37.91
Trade value
$1.64M
% of position
23.6%
8/12/2022
183.13K→140K
Common Shares
Direct
Shares
−47K
Price / share
$38.60
Trade value
$1.81M
% of position
33.6%
8/12/2022
140K→93K
Common Shares
Direct
Shares
−1K
Price / share
$39.15
Trade value
$39.15K
% of position
1.1%
8/12/2022
93K→92K
Common Shares
Direct
Shares
−33.94K
Price / share
$37.76
Trade value
$1.28M
% of position
36.9%
8/15/2022
92K→58.06K
Common Shares
Direct
Shares
−32.06K
Price / share
$38.29
Trade value
$1.23M
% of position
55.2%
8/16/2022
58.06K→26K
Common Shares
Direct
Shares
−20K
Price / share
$38.87
Trade value
$777.40K
% of position
76.9%
8/16/2022
26K→6K
Total
Net shares
−177.13K
Net value
-$6.78M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 8/12/2022 | S · Sale | −43.13K | $37.91 | $1.64M | 23.6% | 183.13K | 140K |
| Common Shares Direct | 8/12/2022 | S · Sale | −47K | $38.60 | $1.81M | 33.6% | 140K | 93K |
| Common Shares Direct | 8/12/2022 | S · Sale | −1K | $39.15 | $39.15K | 1.1% | 93K | 92K |
| Common Shares Direct | 8/15/2022 | S · Sale | −33.94K | $37.76 | $1.28M | 36.9% | 92K | 58.06K |
| Common Shares Direct | 8/16/2022 | S · Sale | −32.06K | $38.29 | $1.23M | 55.2% | 58.06K | 26K |
| Common Shares Direct | 8/16/2022 | S · Sale | −20K | $38.87 | $777.40K | 76.9% | 26K | 6K |
| Total | −177.13K | -$6.78M | ||||||
Derivative Transactions0
No derivative transactions reported